A 26-year FDA scientist and administrator, Pazdur has headed the agency's Oncology Center of Excellence since its creation in ...
Texas A&M scientists have unlocked new potential for astatine-211, a rare and short-lived element, as a highly precise cancer-fighting isotope. Its alpha emissions destroy tumor cells while sparing ...
With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...
Clinical Trials Arena on MSN
Cogent’s stock soars on Phase III gastrointestinal cancer data
"Cogent’s stock soars on Phase III gastrointestinal cancer data" was originally created and published by Clinical Trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback